QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
Los Angeles, CA -- (SBWIRE) -- 05/28/2019 -- Deep brain stimulation (DBS) is a neurosurgical procedure involving the implantation of a medical device called a neurostimulator (sometimes referred to as a 'brain pacemaker'), which sends electrical impulses, through implanted electrodes, to specific targets in the brain (brain nuclei) for the treatment of movement and neuropsychiatric disorders.
Increasing prevalence of neurological disorders is one of the critical factors driving the growth of this market globally. With more than 450 million people worldwide affected by neurological disorders, such as Alzheimer disease, brain injuries, epilepsy, Parkinson's disease (PD), strokes, peripheral neuropathy, and paralysis, the market for DBS has a positive outlook in the coming years. For instance, PD is a progressive neurological disorder that affects the central nervous system resulting in muscle stiffness and slow movement. Although PD cannot be cured completely with medicines, DBS is preferred as it can be used to improve motor symptoms. Moreover, in cases of neurological injuries that lead to paralysis or disability, DBS can be used to restore movement, reduce tremor and dyskinesia, and improve the quality of life. Furthermore, DBS also helps in improving bladder control, restoring hand grasp, and improving walking in patients. Therefore, the increasing number of neurological disorders will bolster the growth of this market in the coming years.
Most DBS systems have received CE mark in Europe and then received approval in the US. Frequent approvals by regulatory services boost the market growth. The rise in the number of products seeking approval may help the market grow at a rapid pace during the forecast period.
Get PDF of this report template: https://www.qyresearch.com/sample-form/form/1119691/global-deep-brain-stimulation-market
This report studies the Deep Brain Stimulation market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
This report focuses on the global top players, covered
Boston Scientific Corp.
Medtronic plc
St. Jude Medical Inc
Adaptive Neuromodulation
Aleva Neurotherapeutics
Beijing Pins Medical
NeuroPace
NeuroSigma
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Implanted pulse generator
The lead
Extension
Market segment by Application, the market can be split into
PD
Epilepsy
Dystonia
OCD
Get Customized Report in your Inbox within 24 hours @: https://www.qyresearch.com/customize-request/form/1119691/global-deep-brain-stimulation-market
Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.